Patients diagnosed with ADC were younger at cancer diagnosis than those diagnosed with NADC (median 37 vs 45 years), had a more recent HIV diagnosis (median 0.8 vs 5.3 years), had spent less time on cART (median 0.0 vs 3.1 years), had lower CD4 count at cancer diagnosis (median 89 vs 376 cells/μL), and were more likely to have a detectable VL (69% vs 30%). The gene discussed is CD4; the disease is cancer.